Posted on September 21st, 2017 in
Events
Ubiquigent will be attending and presenting at the upcoming Discovery on Target meeting (September 25– 29, 2017), Boston, MA. Come and see Jason Brown (Scientific Director) discuss ‘An Integrated Chemistry and Assay Platform to Enable and Support Ubiquitin-System Targeted Drug…
Read more
Targeting kinase enzymes has grown to dominate drug discovery over the last decade, accounting for 30% of current pharma R&D Click on the link below to download our brochure detailing "The Unbiquitin System" and how "The analogous ubiquitin cell signalling…
Read more
The first compound library comprising novel small molecules designed to target deubiquitylase enzymes Click on the link below to download a non-confidential summary of DUBtarget™-001 which includes details of how the library was designed and characterised by screening it using…
Read more
Posted on March 31st, 2017 in
Events
Ubiquigent will be attending and presenting at the upcoming SCI meeting - Targeting the Ubiquitin - Proteasome Pathway on 19th May 2017 at the Studio, Birmingham. If you would like to hear more about our novel ubiquitin system compound libraries…
Read more
Posted on January 19th, 2017 in
News
Ubiquigent awarded Innovate UK grant to develop novel compound libraries targeting deubiquitylase (DUB) enzymes Dundee, UK, 19th January 2017: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has…
Read more
Posted on October 31st, 2016 in
Events
We will be attending the upcoming Bio Europe 2016 conference in Cologne, Germany from 7th - 9th November. Full details of the conference can be found here. If you would like to meet with us at Bio Europe, please either contact us…
Read more
Posted on September 14th, 2016 in
News
Ubiquigent launches the first novel compound library designed to target Deubiquitylase (DUB) enzymes - DUBtarget™-001 Dundee, UK, 14th September, 2016: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it…
Read more
Posted on September 8th, 2016 in
Events
Meet Ubiquigent at the upcoming SCI meeting on the 14th September, Hatfield, UK- Innovation in design, supply and acquisition for compound screening libraries Dr John Harris CChem FRSC, Member of Scientific Advisory Board, Ubiquigent Ltd will be giving a short…
Read more
Posted on May 26th, 2016 in
News
Horizon's X-MAN® cell lines to be made available in conjunction with Ubiquigent's ubiquitin-related Drug Discovery Services Cambridge, UK, 26 May 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies including…
Read more
Posted on May 12th, 2016 in
News
Take a look at a great article that was published today in Nature describing how the Division of Signal Transduction Therapy (DSTT) enables pre-competitive access to ubiquitin system research at the University of Dundee. Our friends at the University of…
Read more
